                </a></li></ul></div><p><strong>Figure 1.  <span>ELISA endpoint titers.</span></strong></p><a id="article1.body1.sec3.sec1.sec1.fig1.caption1.p1" name="article1.body1.sec3.sec1.sec1.fig1.caption1.p1"></a><p>Shown are anti-UK-39 IgG ELISA endpoint titers for individual volunteers of all vaccination groups at baseline (0) and 21 days after each vaccination and one year after the third vaccination. Arrows indicate days of immunization. Only the groups immunized with 10 µg UK-39 or 50 µg UK-39+50 µg AMA49-C1 were followed up for one year.</p>
<span>THISISTHEEND
